scorecardresearch
Add as a preferred source on Google
Thursday, August 13, 2026
TopicGeneric drugs

Topic: Generic drugs

Stocks fall, pharma firms fret. Indian drug manufacturers sweat over Trump’s 100% levy on generics

Trump had announced that non-patented drugmakers would have two years to move production to the US or face a 100% import tariff, which would double a year later.

0% now, 100% in 2 years, 200% by 2029—US plan for generic pharma tariffs & what it means for India

US to impose no tariff on generic pharmaceutical goods initially, before hiking to 200%. Announcement set to impact India as US accounts for third of pharma exports from nation.

As semaglutide goes off patent, weight-loss gold rush begins. Pharma bets big, court case lingers

Several leading Indian drugmakers have already secured regulatory approval or recommendations to produce and market generic versions of the weight loss drugs in India.

How reciprocal Trump tariffs may impact Indian pharma, and become a bitter pill for the US

Spooked by US president's threat, several Indian pharma players lobby for blanket duty waiver on drugs coming from America, with chunk of their earnings hinging on exports to the country.

South Eastern Coalfields Limited opens fourth AMRIT Pharmacy in Bilaspur

Launched in 2015, the AMRIT pharmacies, a flagship initiative of the Ministry of Health and Family Welfare, offer a broad selection of generic and life-saving branded drugs, implants, and surgical supplies at heavily discounted prices.

Alliance of India’s 26 top drugmakers opposes generic drug substitution at Janaushadhi Kendras

Leading drugmakers express apprehension over CDSCO’s proposal to permit generic alternatives for key medications, emphasizing the risk of compromised drug quality.

24 mega-seller drugs set to lose patents in US, big opportunity for Indian drugmakers — govt report

Patent expiry would mean that drugmakers will be able to launch generic versions of the blockbuster drugs, which are typically priced up to 90 percent lower than their innovator drug.

Import alerts, warning letters, drug recalls — why ‘pharmacy to the world’ is facing US FDA heat

New Delhi: On 18 April, Mumbai-headquartered Marksans Pharma, a drugmaker that supplies generic drugs in over 50 countries around the world, received form 483,...

Kerala doctors & researchers plan India’s 1st private drug quality assessment drive

Project follows outcry over NMC rule, now on hold, asking medical practitioners to prescribe generics or face penalty. Dr Cyriac Abby Philips or ‘@TheLiverDoc’ part of project.

Prescribe generics or face penalty? Govt asks NMC to modify controversial rule for doctors

Rule part of Registered Medical Practitioner (Professional Conduct) Regulations, 2023. Opponents include Indian Medical Association, but some see it as a move in the right direction.

On Camera

The Tatas have had rotten luck with Air India

N Chandrasekaran’s exit announcement has left many people at Air India feeling insecure about the future, the last thing the airline needs at the moment.

Dalit finance body beneficiaries nearly halve as House panel flags funding drought, board vacancies

NSFDC beneficiaries fell from 1.18 lakh to 61,394 in a year as a Parliamentary panel flagged no fresh equity, nine board vacancies and weak state agencies.

India seeks 60 new transport aircraft for IAF, invites bids for a $10 billion deal

It is reliably learnt that Airbus, which had initially offered its A400M, is likely to sit it out since its aircraft outweighs requirements with payload capacity of 37 tonnes.

Guru RSS is cautioning shishya Modi govt. Bhagwat’s endorsement of Gen Z has an Indira lesson

It’s evident Bhagwat was watching from a distance and was worried about youth’s anger towards Modi govt. The first thing he did was to demolish any criticism of Gen Z protesters as anti-national.